ROTATEQ™ Post-Marketing Surveillance in the Philippines
NCT01357174 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 915
Last updated 2015-10-30
Summary
This study will collect demographic and safety information on the use of ROTATEQ™ in the Philippines.
Conditions
- Rotavirus Infections
- Gastroenteritis
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 6 Weeks
- Max Age
- 12 Weeks
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2010-09-30
- Completion
- 2010-09-30
More Related Trials
-
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™
NCT01435967 ·Status: COMPLETED
-
A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)
NCT00953056 ·Status: COMPLETED ·Phase: PHASE1
-
Developing World Study for RotaTeq™ (V260-015)(COMPLETED)
NCT00362648 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)
NCT01600092 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants
NCT03507738 ·Status: COMPLETED ·Phase: PHASE1
-
Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab
NCT00737503 ·Status: COMPLETED ·Phase: PHASE4
-
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
NCT00329745 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children
NCT01328925 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
NCT05958771 ·Status: UNKNOWN ·Phase: PHASE3
-
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
NCT01026779 ·Status: COMPLETED
-
Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam
NCT04596696 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
NCT02062385 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam
NCT03367559 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Rotavirus Vaccine Introduction for South Australian Children
NCT01472575 ·Status: UNKNOWN
-
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
NCT01575197 ·Status: COMPLETED ·Phase: PHASE4
-
Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers
NCT00847145 ·Status: COMPLETED ·Phase: PHASE3
-
To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus
NCT04819412 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines
NCT01270503 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)
NCT00718237 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia
NCT03602053 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
NCT00653198 ·Status: COMPLETED
-
Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam
NCT03587389 ·Status: COMPLETED ·Phase: PHASE4
-
Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine
NCT01738074 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 ·Status: COMPLETED
-
An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)
NCT01960725 ·Status: COMPLETED ·Phase: PHASE4